H.M. Sampoerna Tbk. vs Merck Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp695 (market cap 80.84T), while Merck Tbk. trades at Rp3,800 (market cap 1.7T). The key difference: H.M. Sampoerna Tbk. is far larger — about 47.6× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| HMSP | MERK | |
|---|---|---|
Market Cap | 80.84T | 1.7T |
Indicative Equilibrium Price | 695 | 3,850 |
Indicative Equilibrium Volume | 496 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.
Read more on HMSP →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →